Related Experiment Video
Updated: Oct 9, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Artificial heart in terminal stage of dilated cardiomyopathy in childhood]
Insights
Pediatric dilated cardiomyopathy can be fatal. A miniaturized ventricular assist device successfully bridged 12 of 15 children to heart transplantation, improving outcomes for critically ill pediatric patients.
Area of Science:
- Pediatric Cardiology
- Mechanical Circulatory Support
- Congenital Heart Disease
Context:
- Dilated cardiomyopathy in children can rapidly progress to fatal outcomes.
- Intensive medical therapy often fails in pediatric patients with end-stage heart failure.
- Urgent need for effective bridging strategies to cardiac transplantation in pediatric populations.
Purpose:
- To evaluate the efficacy of a miniaturized pulsatile ventricular assist device (Berlin Heart) as a bridge to cardiac transplantation in pediatric patients.
- To assess the safety and outcomes associated with mechanical circulatory support in children with end-stage heart failure.
Summary:
- Fifteen children (4 months–15 years) with severe dilated cardiomyopathy and multiorgan failure received a miniaturized biventricular assist device.
- Twelve of 15 children were successfully bridged to transplantation, with support durations ranging from 1 to 98 days (mean 24 days).
- Complications included hemorrhage, sepsis, pulmonary failure, and one cerebral infarction; seven transplanted children remain in good condition.
Impact:
- Demonstrates the feasibility and effectiveness of ventricular assist devices in pediatric patients, including infants.
- Offers a viable mechanical circulatory support solution for critically ill children awaiting heart transplantation.
- Highlights the potential to improve survival rates in pediatric patients with end-stage heart failure.
Abstract:
In children with dilated cardiomyopathy the disease may progress so rapidly that they die during the waiting period before a suitable donor organ is found. Fifteen children of 4 months to 15 years of age had been in congestive heart failure with multiorgan failure due to dilated cardiomyopathy, where intensive medical treatment had failed. After resuscitation, a miniaturized pulsatile ventricular assist device for the mechanical replacement of heart function was implanted. The biventricular assist device ("Berlin Heart") consists of two extracorporeal pneumatically driven polyurethane blood pumps, with a multi-layer flexible membrane that separates a blood and an air chamber. Four silicon cannulae connect the blood pumps to the patient. A three-leaflet valve prevents blood reflux. The pumps are driven by a pulsatile electropneumatic system. In 12 of the 15 children the bridging to transplantation was successful with a support time of 1 to 98 days (mean 24 days). Nine of them were extubated and mobilized while assisted. Three children died during the support time due to hemorrhage, sepsis, and pulmonary failure. In addition, there was one infarction of the arteria cerebri media. To date seven of the transplanted children are in good condition on follow-up. The beneficial effects of ventricular assist device use are well known in adult patients and with special devices it can be transferred to infants and children in whom longer need for support is anticipated. Even in small infants it is an effective method for bridging to cardiac transplantation.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy

